Eric D. Shaff Seres Therapeutics, Inc. (MCRB) insider trading activity
Eric D. Shaff is CEO and President of Seres Therapeutics, Inc.. Currently has a direct ownership of 170,389 shares of MCRB, which is worth approximately $131,199. The most recent transaction as insider was on Nov 18, 2024, when has been sold 2,505 shares (Common Stock) at a price of $0.54 per share, resulting in proceeds of $1,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
170K
16.71%
3M change
47.37%
12M change
Total Value Held
$131,199
Eric D. Shaff Transaction History
Also insider at
EDS
Eric D. Shaff
CEO and President
Cambridge, MA